Author Response to LTE JCH‐17‐0110

Hexia Xia,Ruixiu Zhang,Xiangrong Sun,Lu Wang,Wei Zhang
DOI: https://doi.org/10.1111/jch.13047
2017-01-01
Abstract:We appreciate the careful reading of our article1 by Ayubi and Safiri.2 The statistical method used in our study was according to chapter 8 (“Logistic Regression”) in The Application of SPSS Version 17.0 in Medical Statistics published in 2010.1 Similar statistical methods can also be found in studies performed by Veltman-Verhulst,2 Zhang,3 and Ashrafi.4 Therefore, we insist that the results of our current study are indisputable. However, we would like to thank Ayubi and Safiri for their kind and professional proposals on our methodology. There are a few points that need to be addressed. Response: In the studies mentioned above, independent variables with P<.05 in the univariate model were included in the multivariate model. The criteria of univariate P values were apparently optional. Compared with P<.2, a P value such as P<.05 was more appropriate for us to screen out the most valuable risk factors. Response: In the study, to detect a difference of 0.80 SD (Cohen's d) in sex hormone–binding globulin between women with and without preeclampsia, at least 86 (n=14 and n=72) patients were included (power of 90% at a 0.05 level). Cohen's d of 0.80 is at the upper limit of what may be considered a medium size effect. Response: In the current study, we performed a preliminary analysis on the risk for preeclampsia with an acquired sample size. Larger prospective cohort studies are needed to identify a clinically useful prediction model such as that by de Wilde5 and an accurate cutoff value for preeclampsia among patients with polycystic ovary syndrome.
What problem does this paper attempt to address?